StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Petros Pharmaceuticals's cash was $3.49M at Jun 30, 2026. For fiscal 2025 it was $5.14M, up 198.9% from the year before. The highest annual figure on record is $23.85M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.14M+198.9%
FY2024Dec 31, 2024$1.72M-87.1%
FY2023Dec 31, 2023$13.34M+41.5%
FY2022Dec 31, 2022$9.43M-60.5%
FY2021Dec 31, 2021$23.85M+39.1%
FY2020Dec 31, 2020$17.14M+698.8%
FY2019Dec 31, 2019$2.15M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.49M-52.4%
Q1 FY2026Mar 31, 2026$4.35M-51.3%
Q4 FY2025Dec 31, 2025$5.14M+198.9%
Q3 FY2025Sep 30, 2025$6.07M+89.5%
Q2 FY2025Jun 30, 2025$7.32M+8.5%
Q1 FY2025Mar 31, 2025$8.93M-13.1%
Q4 FY2024Dec 31, 2024$1.72M-87.1%
Q3 FY2024Sep 30, 2024$3.20M-82.2%
Q2 FY2024Jun 30, 2024$6.75M-8.6%
Q1 FY2024Mar 31, 2024$10.28M+23.6%
Q4 FY2023Dec 31, 2023$13.34M+41.5%
Q3 FY2023Sep 30, 2023$17.97M+60.7%
Q2 FY2023Jun 30, 2023$7.38M-44.5%
Q1 FY2023Mar 31, 2023$8.32M-52.9%
Q4 FY2022Dec 31, 2022$9.43M-60.5%
Q3 FY2022Sep 30, 2022$11.18M+1.4%
Q2 FY2022Jun 30, 2022$13.30M-8.7%
Q1 FY2022Mar 31, 2022$17.67M+3.1%
Q4 FY2021Dec 31, 2021$23.85M+3464.3%
Q2 FY2021Jun 30, 2021$11.03M+1226.2%
Q1 FY2021Mar 31, 2021$14.57M+1175.7%
Q4 FY2020Dec 31, 2020$17.14M+698.8%
Q3 FY2020Sep 30, 2020$669.08K–
Q2 FY2020Jun 30, 2020$831.76K–
Q1 FY2020Mar 31, 2020$1.14M–
Q4 FY2019Dec 31, 2019$2.15M–

More Petros Pharmaceuticals figures

See a number that looks wrong?